Making it stick: Chasing the optimal stem cells for cardiac regeneration

Expert Review of Cardiovascular Therapy

Volumn 12, Issue 11, 2014, Pages 1275-1288

  Quijada, Pearl ^a   Sussman, Mark A ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Adult stem cell; Aging; Cardiochimera; Cardiocluster; Commitment; Communication; Diversity; Microenvironment; Proliferation; Survival

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6 RECEPTOR; SOMATOMEDIN RECEPTOR; STEM CELL FACTOR;

ADULT STEM CELL; AGING; CARDIAC REGENERATION; CARDIAC STEM CELL; CELL COMMUNICATION; CELL PROLIFERATION; CELL SURVIVAL; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; GENETICS; HEALING; HEART; HEART MUSCLE; HUMAN; MECHANICAL STRESS; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NONHUMAN; PARACRINE SIGNALING; REVIEW; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; ANIMAL; CARDIAC MUSCLE CELL; CYTOLOGY; DRUG EFFECTS; HEART FAILURE; PROCEDURES; REGENERATION; STEM CELL;

ANIMALS; HEART; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84911163905     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2014.972941     Document Type: Review

References (122)

1. Laflamme MA, Murry CE. Heart regeneration. Nature 2011;473:326-35
2. Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 1997;272:H220-6
3. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998;83:15-26
4. Porrello ER, Mahmoud AI, Simpson E, et al. Transient regenerative potential of the neonatal mouse heart. Science 2011;331:1078-80
5. Porrello ER, Mahmoud AI, Simpson E, et al. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci USA 2013;110:187-92
6. Mahmoud AI, Kocabas F, Muralidhar SA, et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature 2013;497:249-53
7. Naqvi N, Li M, Calvert JW, et al. A Proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 2014;157:795-807
8. Bolli R, Chugh AR, D'Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011;378:1847-57
9. Nadal-Ginard B, Ellison GM, Torella D. The absence of evidence is not evidence of absence: the pitfalls of cre knock-ins in the C-kit locus. Circ Res 2014. [Epub ahead of print]
10. Ellison GM, Vicinanza C, Smith AJ, et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013;154:827-42
11. van Berlo JH, Kanisicak O, Maillet M, et al. c-kit cells minimally contribute cardiomyocytes to the heart. Nature 2014. [Epub ahead of print]
12. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 2013;113:810-34
13. Isobe KI, Cheng Z, Nishio N, et al. iPSCs, aging and age-related diseases. N Biotechnol 2014. [Epub ahead of print]
14. de Almeida PE, Meyer EH, Kooreman NG, et al. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat Commun 2014;5:3903
15. Burridge PW, Thompson S, Millrod MA, et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011;6:e18293
16. Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-8
17. Chong JJ, Yang X, Don CW, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014. [Epub ahead of print]
18. Yang X, Rodriguez M, Pabon L, et al. Tri-iodo- l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol 2014;72:296-304
19. Shiba Y, Fernandes S, Zhu WZ, et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012;489:322-5
20. Lundy SD, Gantz JA, Pagan CM, et al. Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med 2014;16:319
21. Shiba Y, Filice D, Fernandes S, et al. Electrical integration of human embryonic stem cell-derived cardiomyocytes in a guinea pig chronic infarct model. J Cardiovasc Pharmacol Ther 2014;19:368-81
22. Anderson ME, Goldhaber J, Houser SR, et al. Embryonic stem cell-derived cardiac myocytes are not ready for human trials. Circ Res 2014;115:335-8
23. Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012;485:593-8
24. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-86
25. Fu JD, Stone NR, Liu L, et al. Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State. Stem Cell Reports 2013;1:235-47
26. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72
27. Chen JX, Krane M, Deutsch MA, et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res 2012;111:50-5
28. Fisher SA, Brunskill SJ, Doree C, et al. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev 2014;4:CD007888
29. Bartunek J, Behfar A, Dolatabadi D, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 2013;61:2329-38
30. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012;308:2369-79
31. Nowbar AN, Mielewczik M, Karavassilis M, et al. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ 2014;348:g2688
32. Sumanasekera WK, Tran DM, Sumanasekera TU, et al. Cigarette smoke adversely affects functions and cell membrane integrity in c-kit+ cardiac stem cells. Cell Biol Toxicol 2014;30:113-25
33. Dichgans M, Malik R, Konig IR, et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke 2013;45:24-36
34. Duygu B, Poels EM, da Costa Martins PA. Genetics and epigenetics of arrhythmia and heart failure. Front Genet 2013;4:219
35. Cahill TJ, Ashrafian H, Watkins H. Genetic cardiomyopathies causing heart failure. Circ Res 2013;113:660-75
36. Cosgrove BD, Gilbert PM, Porpiglia E, et al. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med 2014;20:255-64
37. Drummond-Barbosa D. Stem cells, their niches and the systemic environment: an aging network. Genetics 2008;180:1787-97
38. Tumpel S, Rudolph KL. The role of telomere shortening in somatic stem cells and tissue aging: lessons from telomerase model systems. Ann N Y Acad Sci 2012;1266:28-39
39. Sanada F, Kim J, Czarna A, et al. c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy. Circ Res 2013;114:41-55
40. Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science 2014;344:630-4
41. Torella D, Ellison GM, Mendez-Ferrer S, et al. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med 2006;3(Suppl 1):S8-13
42. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008;102:1319-30
43. Dey D, Han L, Bauer M, et al. Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res 2013;112:1253-62
44. Rouhani F, Kumasaka N, de Brito MC, et al. Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet 2014;10:e1004432
45. Cesselli D, Beltrami AP, D'Aurizio F, et al. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 2011;179:349-66
46. Frangogiannis NG. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol 2013;63:185-95
47. Hilgendorf I, Gerhardt LM, Tan TC, et al. Ly-6Chigh monocytes depend on nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res 2014;114:1611-22
48. Hong KU, Li QH, Guo Y, et al. A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res Cardiol 2013;108:346
49. Hong KU, Guo Y, Li QH, et al. c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS ONE 2014;9:e96725
50. Hansson EM, Lindsay ME, Chien KR. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell 2009;5:364-77
51. Segers VF Lee RT. Stem-cell therapy for cardiac disease. Nature 2008;451:937-42
52. Tallini YN, Greene KS, Craven M, et al. c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci USA 2009;106:1808-13
53. Fransioli J, Bailey B, Gude NA, et al. Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 2008;26:1315-24
54. Guo J, Jie W, Shen Z, et al. Li T, Zheng S. SCF increases cardiac stem cell migration through PI3K/AKT and MMP2/9 signaling. Int J Mol Med 2014;34:112-18
55. Chong JJ, Reinecke H, Iwata M, et al. Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev 2013;22:1932-43
56. Bailey B, Fransioli J, Gude NA, et al. Sca-1 knockout impairs myocardial and cardiac progenitor cell function. Circ Res 2012;111:750-60
57. Chong JJ, Chandrakanthan V, Xaymardan M, et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 2011;9:527-40
58. Russell JL, Goetsch SC, Gaiano NR, et al. A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Circ Res 2011;108:51-9
59. D'Amario D, Cabral-Da-Silva MC, Zheng H, et al. Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res 2011;108:1467-81
60. Mohsin S, Khan M, Nguyen J, et al. Rejuvenation of human cardiac progenitor cells with Pim-1 kinase. Circ Res 2013;113:1169-79
61. Brady JJ, Li M, Suthram S, et al. Early role for IL-6 signalling during generation of induced pluripotent stem cells revealed by heterokaryon RNA-Seq. Nat Cell Biol 2013;15:1244-52
62. D'Amario D, Leone AM, Iaconelli A, et al. Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation 2014;129:157-72
63. Kajstura J, Bai Y, Cappetta D, et al. Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res 2012;111:894-906
64. Fischer KM, Cottage CT, Wu W, et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009;120:2077-87
65. Mohsin S, Khan M, Toko H, et al. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol 2012;60:1278-87
66. Cottage CT, Bailey B, Fischer KM, et al. Cardiac progenitor cell cycling stimulated by pim-1 kinase. Circ Res 2010;106:891-901
67. Muraski JA, Rota M, Misao Y, et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 2007;13:1467-75
68. Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73
69. Quijada P, Toko H, Fischer KM, et al. Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells. Circ Res 2012;111:77-86
70. Cottage CT, Neidig L, Sundararaman B, et al. Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells. Stem Cells 2012;30:2512-22
71. Siddiqi S, Sussman MA. Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase. Expert Rev Cardiovasc Ther 2013;11:949-57
72. Siddiqi S, Gude N, Hosoda T, et al. Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge. Circ Res 2008;103:89-97
73. Hariharan N, Sussman MA. Stressing on the nucleolus in cardiovascular disease. Biochim Biophys Acta 2013;1842:798-801
74. Altschuler SJ, Wu LF. Cellular heterogeneity: do differences make a difference? Cell 2010;141:559-63
75. Zhang D, Jin Z, Shi J, et al. The anistropy of field effect mobility of CVD graphene grown on copper foil. Small 2014;10:1761-4
76. Kurazumi H, Kubo M, Ohshima M, et al. The effects of mechanical stress on the growth, differentiation, and paracrine factor production of cardiac stem cells. PLoS ONE 2011;6:e28890
77. Mehling M, Tay S. Microfluidic cell culture. Curr Opin Biotechnol 2014;25:95-102
78. Shah N, Morsi Y, Manasseh R. From mechanical stimulation to biological pathways in the regulation of stem cell fate. Cell Biochem Funct 2014;32:309-25
79. Mosqueira D, Pagliari S, Uto K, et al. Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure. ACS Nano 2014;8:2033-47
80. Deb A. Cell-cell interaction in the heart via Wnt/beta-catenin pathway after cardiac injury. Cardiovasc Res 2014;102:214-23
81. Fang F, Wasserman SM, Torres-Vazquez J, et al. The role of Hath6, a newly identified shear-stress-responsive transcription factor, in endothelial cell differentiation and function. J Cell Sci 2014;127:1428-40
82. Pietronave S, Zamperone A, Oltolina F, et al. Monophasic and biphasic electrical stimulation induces a precardiac differentiation in progenitor cells isolated from human heart. Stem Cells Dev 2013;23:888-98
83. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-21
84. Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115:896-908
85. Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012;379:895-904
86. Xie Y, Ibrahim A, Cheng K, et al. Importance of cell-cell contact in the therapeutic benefits of cardiosphere-derived cells. Stem Cells 2014. [Epub ahead of print]
87. Deb A, Ubil E. Cardiac fibroblast in development and wound healing. J Mol Cell Cardiol 2014;70C:47-55
88. Furtado MB, Costa MW, Pranoto EA, et al. Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ Res 2014;114:1422-34
89. Ramkisoensing AA, de Vries AA, Atsma DE, et al. Interaction between myofibroblasts and stem cells in the fibrotic heart: balancing between deterioration and regeneration. Cardiovasc Res 2014;102:224-31
90. Konstandin MH, Toko H, Gastelum GM, et al. Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction. Circ Res 2013;113:115-25
91. Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature 2009;462:433-41
92. Radisic M, Christman KL. Materials science and tissue engineering: repairing the heart. Mayo Clin Proc 2013;88:884-98
93. Menasche P. Embryonic stem cells for severe heart failure: why and how? J Cardiovasc Transl Res 2012;5:555-65
94. Foldes G, Mioulane M, Kodagoda T, et al. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. Stem Cells Dev 2013;23:467-76
95. Ellison GM, Galuppo V, Vicinanza C, et al. Cardiac stem and progenitor cell identification: different markers for the same cell? Front Biosci (Schol Ed) 2009;2:641-52
96. Palii CG, Vulesevic B, Fraineau S, et al. et al. Enhances Vascular Repair by Injected Human Endothelial Progenitors through Increasing the Expression of TAL1-Dependent Genes. Cell Stem Cell 2014;14:644-57
97. D'Amario D, Fiorini C, Campbell PM, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 2011;108:857-61
98. Kobel S, Lutolf M. High-throughput methods to define complex stem cell niches. Biotechniques 2010;48:ix-xxii
99. Lee ST, White AJ, Matsushita S, et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol 2011;57:455-65
100. Lee WY, Wei HJ, Wang JJ, et al. Vascularization and restoration of heart function in rat myocardial infarction using transplantation of human cbMSC/HUVEC core-shell bodies. Biomaterials 2012;33:2127-36
101. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7
102. Wang W, Itaka K, Ohba S, et al. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials 2009;30:2705-15
103. Hwang HJ, Chang W, Song BW, et al. Antiarrhythmic potential of mesenchymal stem cell is modulated by hypoxic environment. J Am Coll Cardiol 2012;60:1698-706
104. Tang YL, Zhu W, Cheng M, et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009;104:1209-16
105. Wagner W, Roderburg C, Wein F, et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 2007;25:2638-47
106. Saleh FA, Whyte M, Genever PG. Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model. Eur Cell Mater 2011;22:242-57.discussion 257
107. Acquistapace A, Bru T, Lesault PF, et al. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells 2011;29:812-24
108. Islam MQ, Panduri V, Islam K. Generation of somatic cell hybrids for the production of biologically active factors that stimulate proliferation of other cells. Cell Prolif 2007;40:91-105
109. Islam MQ, Ringe J, Reichmann E, et al. Functional characterization of cell hybrids generated by induced fusion of primary porcine mesenchymal stem cells with an immortal murine cell line. Cell Tissue Res 2006;326:123-37
110. Quintana-Bustamante O, Grueso E, Garcia-Escudero R, et al. Cell Fusion Reprogramming Leads to a Specific Hepatic Expression Pattern during Mouse Bone Marrow Derived Hepatocyte Formation In Vivo. PLoS ONE 2012;7:e33945
111. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-73
112. Takei S, Yamamoto M, Cui L, et al. Phenotype-specific cells with proliferative potential are produced by polyethylene glycol-induced fusion of mouse embryonic stem cells with fetal cardiomyocytes. Cell Transplant 2005;14:701-8
113. Smith AJ, Lewis FC, Aquila I, et al. Isolation and characterization of resident endogenous c-Kit(+) cardiac stem cells from the adult mouse and rat heart. Nat Protoc 2014;9:1662-81
114. Gleit ZL, Fuchimoto Y, Yamada K, et al. Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning. Transplantation 2002;74:1535-44
115. Mapara MY, Pelot M, Zhao G, et al. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Biol Blood Marrow Transplant 2001;7:646-55
116. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008;358:362-8
117. Skinner AM, Grompe M, Kurre P. Intra-hematopoietic cell fusion as a source of somatic variation in the hematopoietic system. J Cell Sci 2012;125:2837-43
118. Peterson SE, Westra JW, Paczkowski CM, Chun J. Chromosomal mosaicism in neural stem cells. Methods Mol Biol 2012;438:197-204
119. Peterson SE, Westra JW, Rehen SK, et al. Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One 2011;6:e23018
120. MacArthur JW Jr, Purcell BP, Shudo Y, et al. Sustained release of engineered stromal cell-derived factor 1-alpha from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction. Circulation 2013;128:S79-86
121. Konoplyannikov M, Haider KH, Lai VK, et al. Activation of diverse signaling pathways by ex-vivo delivery of multiple cytokines for myocardial repair. Stem Cells Dev 2013;22:204-15
122. Williams AR, Hatzistergos KE, Addicott B, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013;127:213-23